Are drugs a risk factor of post-ERCP pancreatitis?

Gastrointestinal Endoscopy

Volumn 58, Issue 5, 2003, Pages 696-700

  Perney, Pascal ^a   Berthier, Emile ^b   Pageaux, Georges Philippe ^b   Hillaire Buys, Dominique ^b   Roques, Valérie ^b   Fabbro Peray, Pascale ^b   Melki, Marianne ^b   Hanslik, Bertrand ^b   Bauret, Paul ^b   Larrey, Dominique ^b   Blayac, Jean Pierre ^b   Blanc, François ^b  

^a HÔPITAL SAINT ELOI   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; AZATHIOPRINE; ESTROGEN; MESALAZINE; MORPHINE DERIVATIVE; PREDNISONE; TRIACYLGLYCEROL LIPASE; VALPROIC ACID;

ABDOMINAL PAIN; ADULT; AGED; AMYLASE BLOOD LEVEL; ARTICLE; CANNULATION; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPIC SPHINCTEROTOMY; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; ODDI SPHINCTER; PANCREATITIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; VOMITING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AZATHIOPRINE; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; DRUG THERAPY; ESTROGENS; FEMALE; HUMANS; MALE; MESALAMINE; MIDDLE AGED; MORPHINE DERIVATIVES; MULTIVARIATE ANALYSIS; PANCREATITIS; PREDNISONE; RETROSPECTIVE STUDIES; RISK FACTORS; VALPROIC ACID;

EID: 10744226717     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5107(03)02019-4     Document Type: Article

References (27)

1. Freeman ML, Nelson DB, Sherman S, Haber GB, Herman ME, Dorsher PJ, et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med 1996;335:909-18.
2. Loperfido S, Angelini G, Benedetti G, Chilovi F, Costan F, De Berardinis F, et al. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc 1998;48:1-10.
3. Sherman S, Ruffolo TA, Hawes RH, Lehman GA. Complications of endoscopic sphincterotomy: a prospective series with emphasis on the increased risk associated with sphincter of Oddi dysfunction and nondilated bile ducts. Gastroenterology 1991;101:1068-75.
4. Gottlieb K, Sherman S. ERCP and biliary endoscopic sphincterotomy-induced pancreatitis. Gastrointest Endosc Clin N Am 1998;8:87-114.
5. Deviere J, Le Moine O, Van Laethem JL, Eisendrath P, Ghilain A, Severs N, Cohard M. Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography. Gastroenterology 2001;120:498-505.
6. Freeman ML, DiSario JA, Nelson DB, Fennerty B, Lee SG, Bjorkman DJ, et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc 2001; 54:425-34.
7. Dukes MNG, Beeley L, Aronson JK, Van Boxtel CJ, editors. Side effects of drugs annual. 1st to 21st eds. Amsterdam: Elsevier; 1977-1998.
8. Mallory H, Kern F Jr. Drug-induced pancreatitis: a critical review. Gastroenterology 1980;78:813-20.
9. Runzi M, Layer P. Drug-associated pancreatitis: facts and fiction. Pancreas 1996;13:100-9.
10. Frick TW, Speiser DE, Bimmler D, Largiader F. Drug-induced acute pancreatitis: further criticism. Dig Dis 1993;11:113-32.
11. McArthur KE. Review article: drug-induced pancreatitis. Aliment Pharmacol Ther 1996;10:23-38.
12. Biour M, Delcenserie R, Grangé JD, Weissenburger J. Conférence de consensus: Pancréatotoxicité des médicaments. Gastroenterol Clin Biol 2001;25:1S22-7.
13. Dukes MNG, editor. Meyler's side effects of drugs. 6th to 13th eds. Amsterdam: Elsevier; 1968-1996.
14. Ringdoc Profile. 35-Adverse Reactions. 20th to 37th eds. London: Derwent Publications; 1983-2000.
15. Betrosian AP, Balla M, Papanikolaou M, Kofinas G, Georgiadis G. Post-operative pancreatitis after propofol administration [letter]. Acta Anaesthesiol Scand 2001;45: 1052.
16. Chen YK, Abdulian JD, Escalante-Glorsky S, Youssef AI, Foliente RL, Collen MJ. Clinical outcome of post-ERCP pancreatitis: relationship to history of previous pancreatitis. Am J Gastroenterol 1995;90:2120-3.
17. Hosmer WH, Lemeshow S. Applied logistic regression. New York: John Wiley; 1989.
18. Mehta SN, Pavone E, Barkun JS, Bouchard S, Barkun AN. Predictors of post-ERCP complications in patients with suspected choledocholithiasis. Endoscopy 1998;30:457-63.
19. Sherman S, Hawes RH, Rathgaber SW, Uzer MF, Smith MT, Khusro QE, et al. Post-ERCP pancreatitis: randomized, prospective study comparing a low- and high-osmolality contrast agent. Gastrointest Endosc 1994;40:422-7.
20. Chen YK, Foliente RL, Santoro MJ, Walter MH, Collen MJ. Endoscopic sphincterotomy-induced pancreatitis: increased risk associated with non-dilated bile duct and sphincter of Oddi dysfunction. Am J Gastroenterol 1994;89:327-33.
21. Deans GT, Sedman P, Martin DF, Royston CM, Leow CK, Thomas WE, Brough WA. Are complications of endoscopic sphincterotomy age related? Gut 1997;41:545-8.
22. Sherman S, Lehman GA. ERCP- and endoscopic sphincterotomy-induced pancreatitis. Pancreas 1991;6:350-67.
23. Cohen SA, Siegel JE, Kasmin FE. Complications of diagnostic and therapeutic ERCP. Abdom Imaging 1996;21:385-94.
24. Saluja AK, Steer ML. Pathophysiology of acute pancreatitis: role of cytokines and other mediators of inflammation. Digestion 1999;60:27-33.
25. Norman JG. New approaches to acute pancreatitis: role of inflammatory mediators. Digestion 1999;60:57-60.
26. Van Laethem JL, Eskinasi R, Louis H, Rickaert F, Robberecht P, Deviere J. Multisystemic production of interleukin 10 limits the severity of acute pancreatitis in mice. Gut 1998;43:408-13.
27. Hastier P, Demarquay JF, Maes B, Caroli-Bosc FX, Dumas R, Delmont J, Chichmanian RM. Acute pancreatitis induced by codeine-acetaminophen association: a case report with positive rechallenge. Pancreas 1996;13:324-6.